Atlas Trials

Xinnate AB

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xinnate AB

RecordFirmDate
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study (NCT06594393)Xinnate AB2026-01-30
Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa. (NCT05378997)Xinnate AB2022-04-07

Track Xinnate AB automatically

Every clearance here is in the API, with alerts when new ones post.